TITLE

Gambogic acid-loaded magnetic Fe3O4 nanoparticles inhibit Panc-1 pancreatic cancer cell proliferation and migration by inactivating transcription factor ETS1

AUTHOR(S)
Cailian Wang; Haijun Zhang; Yan Chen; Fangfang Shi; Baoan Chen
PUB. DATE
January 2012
SOURCE
International Journal of Nanomedicine;2012, Vol. 7, p781
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
82508846

 

Related Articles

  • Suppression of the Epidermal Growth Factor Receptor Inhibits Epithelial-Mesenchymal Transition in Human Pancreatic Cancer PANC-1 Cells. Chang, Zhi-Gang; Wei, Jun-Min; Qin, Chang-Fu; Hao, Kun; Tian, Xiao-Dong; Xie, Kun; Xie, Xue-Hai; Yang, Yin-Mo // Digestive Diseases & Sciences;May2012, Vol. 57 Issue 5, p1181 

    Background: Aberrant expression of epidermal growth factor receptor (EGFR) has been detected in pancreatic cancer; however, the mechanisms of EGFR in inducing pancreatic cancer development have not been adequately elucidated. The objective of this study was to determine the role of EGFR in...

  • Caffeic Acid Phenethyl Ester Inhibits Epithelial-Mesenchymal Transition of Human Pancreatic Cancer Cells. Ming-Jen Chen; Shou-Chuan Shih; Horng-Yuan Wang; Ching-Chung Lin; Chia-Yuan Liu; Tsang-En Wang; Cheng-Hsin Chu; Yu-Jen Chen // Evidence-based Complementary & Alternative Medicine (eCAM);2013, Vol. 2013, p1 

    Background. This study aimed to investigate the effect of propolis component caffeic acid phenethyl ester (CAPE) on epithelial-mesenchymal transition (EMT) of human pancreatic cancer cells and the molecular mechanisms underlying these effects. Methods. The transforming growth factor β...

  • Functional analysis of LOXL2 in pancreatic carcinoma. Rückert, Felix; Joensson, Peer; Saeger, Hans-Detlev; Grützmann, Robert; Pilarsky, Christian // International Journal of Colorectal Disease;Mar2010, Vol. 25 Issue 3, p303 

    Lysyl oxidase-like 2 (LOXL2) plays a part in epithelial–mesenchymal transition (EMT) by stabilizing the transcription factor SNAI1. Previous studies showed that LOXL2 is one of the most highly and specifically upregulated genes in pancreatic cancer. LOXL2 was also found to be strongly...

  • Effects of Suppressor of Cytokine Signaling-1 Silencing on the Proliferation and Interferon Gamma Susceptibility of Human Pancreatic Cancer Cells. LYU Qinglin; WANG Juan; CHEN Liping // Tianjin Medical Journal;Sep2014, Vol. 42 Issue 9, p863 

    Objective To detect the changes of cell proliferation and IFN-γ susceptibility of human pancreatic cancer cells after suppressor of cytokine signaling-1 (SOCS1) gene silencing, and to explore the SOCS1 as the target of anti-tumor therapy through enhancing the function of IFN-γ. Methods...

  • Targeting Insulin-Like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis. Subramani, Ramadevi; Lopez-Valdez, Rebecca; Arumugam, Arunkumar; Nandy, Sushmita; Boopalan, Thiyagarajan; Lakshmanaswamy, Rajkumar // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Pancreatic cancer is one of the most lethal cancers. Increasing incidence and mortality indicates that there is still much lacking in detection and management of the disease. This is partly due to a lack of specific symptoms during early stages of the disease. Several growth factor receptors...

  • Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. Shimasaki, Takeo; Ishigaki, Yasuhito; Nakamura, Yuka; Takata, Takanobu; Nakaya, Naoki; Nakajima, Hideo; Sato, Itaru; Zhao, Xia; Kitano, Ayako; Kawakami, Kazuyuki; Tanaka, Takuji; Takegami, Tsutomu; Tomosugi, Naohisa; Minamoto, Toshinari; Motoo, Yoshiharu // Journal of Gastroenterology;Mar2012, Vol. 47 Issue 3, p321 

    Background: Pancreatic cancer is obstinate and resistant to gemcitabine, a standard chemotherapeutic agent for the disease. We previously showed a therapeutic effect of glycogen synthase kinase-3β (GSK3β) inhibition against gastrointestinal cancer and glioblastoma. Here, we investigated...

  • Simultaneous silencing of XIAP and survivin causes partial mesenchymal-epithelial transition of human pancreatic cancer cells via the PTEN/PI3K/Akt pathway. XIAO-PING YI; TONG HAN; YI-XIONG LI; XUE-YING LONG; WEN-ZHENG LI // Molecular Medicine Reports;2015, Vol. 12 Issue 1, p601 

    Pancreatic cancer has one of the highest mortality rates among malignant tumors and is characterized by rapid invasion, early metastasis and chemoresistance. X-linked inhibitor of apoptosis (XIAP) and survivin are two of the most important members of the IAP family. Previous studies have shown...

  • Dimethylenastron suppresses human pancreatic cancer cell migration and invasion in vitro via allosteric inhibition of mitotic kinesin Eg5. Sun, Xiao-dong; Shi, Xing-juan; Sun, Xiao-ou; Luo, You-guang; Wu, Xiao-jing; Yao, Chang-fu; Yu, Hai-yang; Li, Deng-wen; Liu, Min; Zhou, Jun // Acta Pharmacologica Sinica;Dec2011, Vol. 32 Issue 12, p1543 

    Aim:The mitotic kinesin Eg5 plays a critical role in bipolar spindle assembly, and its inhibitors have shown impressive anticancer activity in preclinical studies. This study was undertaken to investigate the effect of dimethylenastron, a specific inhibitor of Eg5, on the migration and invasion...

  • JWA gene regulates PANC-1 pancreatic cancer cell behaviors through MEK-ERK1/2 of the MAPK signaling pathway. YUAN-YUAN WU; TIE-LIANG MA; ZHI-JUN GE; JIE LIN; WEI-LIANG DING; JIA-KE FENG; SU-JUN ZHOU; GUO-CHANG CHEN; YONG-FEI TAN; GUO-XING CUI // Oncology Letters;2014, Vol. 8 Issue 4, p1859 

    The present study aimed to investigate the role of JWA gene in the proliferation, apoptosis, invasion and migration of PANC-1 pancreatic cancer cells and the effect on the MAPK signaling pathway. Human PANC-1 pancreatic cancer cells were cultured in vitro, and small interfering RNA (siRNA) was...

  • Pioglitazone inhibits the proliferation and metastasis of human pancreatic cancer cells. ITASU NINOMIYA; KEISUKE YAMAZAKI; KATSUNOBU OYAMA; HIRONORI HAYASHI; HIDEHIRO TAJIMA; HIROHISA KITAGAWA; SACHIO FUSHIDA; TAKASHI FUJIMURA; TETSUO OHTA // Oncology Letters;2014, Vol. 8 Issue 6, p2709 

    Proliferator-activated receptor-γ (PPAR-γ) is a nuclear receptor that acts as a transcription factor in several types of tissue. PPAR-γ ligands are known to inhibit numerous cancer cell processes, including pancreatic cancer cell proliferation through terminal differentiation. Previous...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics